Schroder Investment Management Group’s Takeda Pharmaceutical TAK Stock Holding History

Schroder Investment Management Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,366	Closed	-$135K	–	1612
2021 Q1	$135K	Sell	7,366 -14	-0.2%	-$252	﹤0.01%	1359
2020 Q4	$135K	Sell	7,380 -22,456	-75%	-$394K	﹤0.01%	1350
2020 Q3	$512K	Buy	29,836 +28,742	+2,627%	+$523K	﹤0.01%	1089
2020 Q2	$20K	Hold	1,094	–	–	﹤0.01%	1214
2020 Q1	$17K	Hold	1,094	–	–	﹤0.01%	1264
2019 Q4	$22K	Sell	1,094 -2,295	-68%	-$43.9K	﹤0.01%	1256
2019 Q3	$59K	Sell	3,389 -875	-21%	-$15.1K	﹤0.01%	1222
2019 Q2	$75K	Hold	4,264	–	–	﹤0.01%	1145
2019 Q1	$87K	Buy	+4,264	New	+$85.8K	﹤0.01%	1109

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Schroder Investment Management Group's TAK Position: Q2 2021 in Review

Schroder Investment Management Group sold out of Takeda Pharmaceutical (TAK) in Q2 2021, closing a stake of 7,366 shares — an estimated $135K sold.

Schroder Investment Management Group first reported a position in TAK in Q1 2019 and held it in 9 quarters. The position peaked at $512K in Q3 2020. 304 funds tracked by Wall St. Rank hold TAK as of Q2 2021.

Schroder Investment Management Group reported no remaining Takeda Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Schroder Investment Management Group sold 7,366 Takeda Pharmaceutical shares in Q2 2021, an estimated $135K.
Schroder Investment Management Group first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 9 quarters.
Schroder Investment Management Group's Takeda Pharmaceutical position peaked at $512K in Q3 2020.
304 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2021.

Based on Schroder Investment Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.